What You Didn't Learn in Medical School About...

Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-grou ...  Show more

Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights. Credit available for this activity expires: 02/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.meds ...  Show more

You’ve probably heard of these letters: THC, CBD, but what about CBG or CBN, how about terpenes, or phytocannabinoids?What do they really mean and how can we optimize our experience with them.Now you may be thinking this is a weed show for stoners, but it’s not. Not even close!Th ...  Show more

<pre class="syntaxhighlighter-pre" data-syntaxhighlighter-params= "brush: xml; gutter: false; theme: Midnight" data-theme= "Midnight">Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit ...  Show more

Dr. Ilana Braun and Dr. Eric Roeland join us on the ASCO Guidelines podcast to discuss the latest evidence-based recommendations on cannabis and cannabinoids in adults with cancer. They discuss nonjudgmental patient-clinician communication, the relatively narrow cancer-related in ...  Show more

What are practical phrases can you incorporate to help patients who use drugs? What changes can you make to ensure person-first language? What safe drug practices can you advise? What is MOUD?Show notes, Transcript and References: https://www.coreimpodcast.com/2021/09/29/5-pearls ...  Show more